Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.

Calcified tissue international·2025
Same author

Community-based serological screening for Chagas disease in London: a cross-sectional, observational pilot study.

BMJ public health·2025
Same author

Estimating the population size of gay, bisexual, and other men who have sex with men in four major provinces in Canada: A descriptive study using data from a population-based survey.

PloS one·2025
Same author

Chronic Pain in a Modern Virally Suppressed HIV Cohort: Associations with Comorbidities Depression and Disability.

Research square·2025
Same author

Global Comparison and Future Trends of Major Food Proteins: Can Shellfish Contribute to Sustainable Food Security?

Foods (Basel, Switzerland)·2025
Same author

Beyond total depressive symptoms: Differential associations between depressive domains, HIV status and disease characteristics.

Journal of psychosomatic research·2025
Same journal

Early trends in outpatient addiction care for cannabis use disorder following cannabis legalization in Germany: Evidence from National Monitoring Data.

Addiction (Abingdon, England)·2026
Same journal

Zyn and other oral nicotine pouch use, correlates, and advertising exposure among a national sample of United States adolescents, young adults and adults.

Addiction (Abingdon, England)·2026
Same journal

Trends in new psychoactive substance poisonings in the Netherlands: A 14-year retrospective analysis (2012-2025).

Addiction (Abingdon, England)·2026
Same journal

Theorizing ahead of the data: A commentary on Piper et al.

Addiction (Abingdon, England)·2026
Same journal

Longitudinal association of switching to dual cigarette and e-cigarette use vs. continued exclusive cigarette smoking with tobacco-specific nitrosamine and nicotine intake.

Addiction (Abingdon, England)·2026
Same journal

Novel product, familiar challenges: Navigating uncertainty in oral nicotine pouch regulation.

Addiction (Abingdon, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Extending drug ethno-epidemiology using agent-based modelling.

David Moore1, Anne Dray, Rachael Green

  • 1National Drug Research Institute, Curtin University of Technology, Australia. d.moore@curtin.edu.au

Addiction (Abingdon, England)
|October 7, 2009
PubMed
Summary
This summary is machine-generated.

Agent-based modelling enhanced the integration of ethno-epidemiological data on psychostimulant use and harms in young Australians. This approach allowed testing interventions like pill-testing to inform harm reduction policies.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Related Experiment Videos

Last Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Area of Science:

  • Public Health
  • Computational Social Science
  • Drug Use Research

Background:

  • Young Australians experience significant harms from psychostimulant use.
  • Integrating diverse data sources like ethnographic and epidemiological data presents challenges.

Purpose of the Study:

  • To demonstrate how agent-based modelling improves ethno-epidemiological data integration for studying psychostimulant use.
  • To test the potential impact of interventions on drug-related harms.

Main Methods:

  • Agent-based modelling (SimAmph)
  • Ethnographic fieldwork
  • In-depth interviews
  • Epidemiological surveys

Main Results:

  • Agent-based modelling facilitated structured integration of ethnographic and epidemiological data.
  • The SimAmph model allowed testing the impact of simulated ecstasy pill-testing on harm prevalence.
  • Challenges included managing epistemological differences and diverse participant samples.

Conclusions:

  • Agent-based modelling effectively integrated ethno-epidemiological data for psychostimulant use research.
  • This approach enabled testing interventions to reduce drug-related harms.
  • It established a collaborative framework for synthesizing diverse data to generate new knowledge.